Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and cudc-907

sorafenib has been researched along with cudc-907 in 1 studies

Compound Research Comparison

Studies
(sorafenib)		Trials
(sorafenib)		Recent Studies (post-2010)
(sorafenib)		Studies
(cudc-907)		Trials
(cudc-907)		Recent Studies (post-2010) (cudc-907)
6,5207305,25157355

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)cudc-907 (IC50)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformHomo sapiens (human)0.0869
Histone deacetylase 3Homo sapiens (human)0.0029
Phosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)0.0712
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)0.0246
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)0.0439
Serine/threonine-protein kinase mTORHomo sapiens (human)0.308
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)0.209
Histone deacetylase 4Homo sapiens (human)0.3233
DNA-dependent protein kinase catalytic subunitHomo sapiens (human)3.673
Histone deacetylase 1Homo sapiens (human)0.0022
Histone deacetylase 7Homo sapiens (human)0.2828
Histone deacetylase 2Homo sapiens (human)0.0052
Polyamine deacetylase HDAC10Homo sapiens (human)0.0036
Histone deacetylase 11 Homo sapiens (human)0.2039
Histone deacetylase 8Homo sapiens (human)0.145
Histone deacetylase 6Homo sapiens (human)0.1039
Histone deacetylase 9Homo sapiens (human)0.4616
Histone deacetylase 5Homo sapiens (human)0.4684
Nuclear receptor corepressor 2Homo sapiens (human)0.0025

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, D; Goh, WH; Soh, CK; Wang, H1

Other Studies

1 other study(ies) available for sorafenib and cudc-907

ArticleYear
Design, Synthesis, and Preclinical Evaluation of Fused Pyrimidine-Based Hydroxamates for the Treatment of Hepatocellular Carcinoma.
    Journal of medicinal chemistry, 2018, 02-22, Volume: 61, Issue:4

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Screening Assays, Antitumor; Heterografts; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2018